Indaptus Therapeutics, Inc. (INDP) Misses Q2 EPS by 890c
Tweet
Share
E-mailGet Alerts INDP Hot Sheet
Join SI Premium – FREE
Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q2 EPS of ($9.09), $8.90 worse than the analyst estimate of ($0.19).
For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Lazard Global Total Return fund declares $0.1534 monthly distribution
- Cytek faces $56M damages award in Beckman Coulter patent case
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
